ivabradine
Megjelenés
| Clinical data | |
|---|---|
| Pronunciation | /ɪˈvæbrədiːn/ |
| Trade names | Corlanor, Procoralan, others |
| Other names | S-16257 |
| AHFS/Drugs.com | Monograph |
| MedlinePlus | a615027 |
| License data |
|
| Routes of administration | By mouth |
| ATC code | |
| Legal status | |
| Legal status | |
| Pharmacokinetic data | |
| Bioavailability | 40% |
| Protein binding | 70% |
| Metabolism | Liver (first-pass) >50%, CYP3A4-mediated |
| Elimination half-life | 6 hours |
| Excretion | Kidney and fecal |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| IUPHAR/BPS | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C27H36N2O5 |
| Molar mass | 468.594 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |
Főnév
ivabradine (tsz. ivabradines)
- ivabradine - Szótár.net (en-hu)
- ivabradine - Sztaki (en-hu)
- ivabradine - Merriam–Webster
- ivabradine - Cambridge
- ivabradine - WordNet
- ivabradine - Яндекс (en-ru)
- ivabradine - Google (en-hu)
- ivabradine - Wikidata
- ivabradine - Wikipédia (angol)